IP Library Granted Patent US 12,310,849
Granted Patent B2
US 12,310,849 · App. 18/301,399 · Granted May 27, 2025

Valve prosthesis

Inventors: Joseph H. Gorman, III (Lower Gwynedd, PA); Robert C. Gorman (Lower Gwynedd, PA); Matthew J. Gillespie (Bryn Mawr, PA)
Assignee: MAJORO CARDIAC INNOVATIONS, LLC
A61F2/2418A61F2/24A61F2/2409A61F2/2436A61F2210/0004A61F2210/0014A61F2210/0061A61F2210/0076A61F2220/0008A61F2230/0054A61F2230/0058A61F2230/0078A61F2250/003A61F2250/0039A61F2250/0069
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,310,849
App. No.
18/301,399
Granted
May 27, 2025
Kind
B2
Abstract

The present disclosure relates to valve replacement devices that are foldable for catheter-based deployment to the site of implantation, as well as systems for the delivery of valve prostheses, including prostheses having the special characteristics of the disclosed valve replacement devices. The devices include highly effective adhering mechanisms for secure and enduring precision implantation. The adhering mechanisms may employ a unique sealing mechanism that includes a cuff that expands slowly whereby the device is not secured in place until the completion of the implantation procedure. The implanted device, optionally together with the cuff, prevents perivalvular leaks and incorporate an appropriate leaflet system for reliable functioning in situ.

Claims (81)

1. A prosthetic device comprising:

an at least partially self-expanding stent adapted for percutaneous delivery and anchoring in a valve annulus, said stent comprising

an expanded and an unexpanded state;

a long axis;

a middle region having first and second ends and comprising a framework that defines inner and outer surfaces;

a lower flange portion at the first end of the middle region that comprises a first flange end that is attached to the middle region and an opposed second flange end that is spaced from the first end, wherein at least part of the lower flange portion includes a central portion that extends between the first flange end and the second flange end and that has a linear configuration when the stent is in the expanded state and when the stent is in the unexpanded state;

when said stent is in the unexpanded state, the lower flange portion is oriented substantially along the long axis of the stent;

when said stent transitions from the unexpanded state to the expanded state, the lower flange portion changes its orientation relative to the middle region of the stent; and

the lower flange portion is adapted to anchor the stent within the valve annulus by grasping tissue at the ventricular side of the annulus by enfolding the tissue between the lower flange portion and the outer surface of the middle region as the stent transitions from the unexpanded state to the expanded state; and

a valve comprising at least one leaflet fixedly attached to the inner surface of the middle region of the stent,

wherein when the stent transitions from the unexpanded state to the expanded state, the lower flange portion transitions in space so that the second flange end of the lower flange portion moves closer to the middle region of the stent.

2. The prosthetic device according to claim 1 , wherein the lower flange portion comprises a plurality of flange elements.

3. The prosthetic device according to claim 1 , wherein the lower flange portion is oriented substantially parallel relative to the long axis of the stent when the stent is in the unexpanded state and is substantially parallel relative to the long axis of the stent when the stent is in the expanded state.

4. The prosthetic device according to claim 1 , wherein the second flange end of the lower flange portion comprises an arc that extends from the central portion.

5. The prosthetic device according to claim 1 , wherein the lower flange portion comprises an arc extending from the first flange end to the second flange end as the lower flange portion is being expanded, wherein the lower flange portion bends back toward the middle region of the stent, and

wherein the lower flange portion is substantially parallel relative to the long axis of the stent when the stent is in the expanded state.

6. A prosthetic device comprising:

an at least partially self-expanding stent adapted for percutaneous delivery and anchoring in a valve annulus, said stent comprising

an expanded and an unexpanded state;

a long axis;

a middle region having first and second ends and comprising a framework that defines inner and outer surfaces;

a lower flange portion at the first end of the middle region that comprises a first flange end that is attached to the middle region and an opposed second flange end that is spaced from the first end;

when said stent is in the unexpanded state, the lower flange portion is oriented substantially along the long axis of the stent;

when said stent transitions from the unexpanded state to the expanded state, the lower flange portion changes its orientation relative to the middle region of the stent; and

the lower flange portion is adapted to anchor the stent within the valve annulus by enfolding tissue at the ventricular side of the annulus between the lower flange portion and the outer surface of the middle region as the stent transitions from the unexpanded state to the expanded state; and

a valve comprising at least one leaflet fixedly attached to the inner surface of the middle region of the stent,

wherein, when the stent transitions from the unexpanded state to the expanded state, the lower flange portion transitions in space so that the second flange end of the lower flange portion bends back toward the middle region of the stent, and

wherein at least part of the lower flange portion includes a central portion that extends between the first flange end and the second flange end and that has a linear configuration when the stent is in the expanded state and when the stent is in the unexpanded state.

7. The prosthetic device according to claim 6 , wherein the lower flange portion comprises a plurality of flange elements.

8. The prosthetic device according to claim 6 , wherein the lower flange portion is oriented substantially parallel relative to the long axis of the stent when the stent is in the unexpanded state and is substantially parallel relative to the long axis of the stent when the stent is in the expanded state.

9. The prosthetic device according to claim 6 , wherein the second flange end of the lower flange portion comprises an arc that extends from the central portion.

10. The prosthetic device according to claim 6 , wherein the lower flange portion comprises an arc extending from the first flange end to the second flange end as the lower flange portion is being expanded, wherein the lower flange portion bends back toward the middle region of the stent, and

wherein the lower flange portion is substantially parallel relative to the long axis of the stent when the stent is in the expanded state.

11. A prosthetic device comprising:

an at least partially self-expanding stent adapted for percutaneous delivery and anchoring in a valve annulus, said stent comprising

an expanded and an unexpanded state;

a long axis;

a middle region having first and second ends and comprising a framework that defines inner and outer surfaces;

a lower flange portion at the first end of the middle region that comprises a first flange end that is attached to the middle region and an opposed second flange end that is spaced from the first end;

when said stent is in the unexpanded state, the lower flange portion is oriented substantially along the long axis of the stent;

when said stent transitions from the unexpanded state to the expanded state, the lower flange portion changes its orientation relative to the middle region of the stent; and

the lower flange portion is adapted to anchor the stent within the valve annulus by enfolding tissue at the ventricular side of the annulus between the lower flange portion and the outer surface of the middle region as the stent transitions from the unexpanded state to the expanded state; and

a valve comprising at least one leaflet fixedly attached to the inner surface of the middle region of the stent,

wherein, when the stent transitions from the unexpanded state to the expanded state, the lower flange portion transitions in space so that the second flange end of the lower flange portion bends back to a position that faces the middle region and is substantially parallel relative to the long axis of the stent,

wherein the lower flange portion comprises an arc extending from the first flange end to the second flange end as the lower flange portion is being expanded, wherein the lower flange portion bends back toward the middle region of the stent, and

wherein the lower flange portion is substantially parallel relative to the long axis of the stent when the stent is in the expanded state.

12. The prosthetic device according to claim 11 , wherein at least part of the lower flange portion includes a central portion that extends between the first flange end and the second flange end and that has a linear configuration when the stent is in the expanded state and when the stent is in the unexpanded state.

13. The prosthetic device according to claim 11 , wherein the lower flange portion comprises a plurality of flange elements.

14. The prosthetic device according to claim 11 , wherein the lower flange portion is oriented substantially parallel relative to the long axis of the stent when the stent is in the unexpanded state.

15. The prosthetic device according to claim 11 , wherein the second flange end of the lower flange portion comprises an arc that extends from the central portion.

16. A prosthetic device comprising:

an at least partially self-expanding stent adapted for percutaneous delivery and anchoring in a valve annulus, said stent comprising

an expanded and an unexpanded state;

a long axis;

a middle region having first and second ends and comprising a framework that defines inner and outer surfaces;

a lower flange portion at the first end of the middle region that comprises a first flange end that is attached to the middle region and an opposed second flange end that is spaced from the first end;

when said stent is in the unexpanded state, the lower flange portion is oriented substantially along the long axis of the stent;

when said stent transitions from the unexpanded state to the expanded state, the lower flange portion changes its orientation relative to the middle region of the stent; and

the lower flange portion is adapted to anchor the stent within the valve annulus by enfolding tissue at the ventricular side of the annulus between the lower flange portion and the outer surface of the middle region as the stent transitions from the unexpanded state to the expanded state; and

a valve comprising at least one leaflet fixedly attached to the inner surface of the middle region of the stent,

wherein, when the stent transitions from the unexpanded state to the expanded state, the lower flange portion transitions in space so that the second flange end of the lower flange portion bends back toward the middle region of the stent, and

wherein the lower flange portion is oriented substantially parallel relative to the long axis of the stent when the stent is in the unexpanded state and is substantially parallel relative to the long axis of the stent when the stent is in the expanded state.

17. The prosthetic device according to claim 16 , wherein the lower flange portion comprises a plurality of flange elements.

18. The prosthetic device according to claim 16 , wherein the second flange end of the lower flange portion comprises an arc that extends from the central portion.

19. The prosthetic device according to claim 16 , wherein the lower flange portion comprises an arc extending from the first flange end to the second flange end as the lower flange portion is being expanded, wherein the lower flange portion bends back toward the middle region of the stent, and

wherein the lower flange portion is substantially parallel relative to the long axis of the stent when the stent is in the expanded state.

20. A prosthetic device comprising:

an at least partially self-expanding stent adapted for percutaneous delivery and anchoring in a valve annulus, said stent comprising

an expanded and an unexpanded state;

a long axis;

a middle region having first and second ends and comprising a framework that defines inner and outer surfaces;

a lower flange portion at the first end of the middle region that comprises a first flange end that is attached to the middle region and an opposed second flange end that is spaced from the first end;

when said stent is in the unexpanded state, the lower flange portion is oriented substantially along the long axis of the stent;

when said stent transitions from the unexpanded state to the expanded state, the lower flange portion changes its orientation relative to the middle region of the stent; and

the lower flange portion is adapted to anchor the stent within the valve annulus by enfolding tissue at the ventricular side of the annulus between the lower flange portion and the outer surface of the middle region as the stent transitions from the unexpanded state to the expanded state; and

a valve comprising at least one leaflet fixedly attached to the inner surface of the middle region of the stent,

wherein, when the stent transitions from the unexpanded state to the expanded state, the lower flange portion transitions in space so that the second flange end of the lower flange portion bends back toward the middle region of the stent,

wherein the lower flange portion comprises an arc extending from the first flange end to the second flange end as the lower flange portion is being expanded, wherein the lower flange portion bends back toward the middle region of the stent, and

wherein the lower flange portion is substantially parallel relative to the long axis of the stent when the stent is in the expanded state.

21. The prosthetic device according to claim 20 , wherein the lower flange portion comprises a plurality of flange elements.

22. The prosthetic device according to claim 20 , wherein the second flange end of the lower flange portion comprises an arc that extends from the central portion.

Assignments (6)
CORRECTIVE ASSIGNMENT TO CORRECT THE TYPOGRAPHICAL ERROR IN THE ASSIGNEE'S NAME. PREVIOUSLY RECORDED ON REEL 68788 FRAME 653. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Nov 19, 2024
From: GORMAN, ROBERT C., MD; GILLESPIE, MATTHEW J., MD; GORMAN, JOSEPH H., III, MD
To: MAJORO CARDIAC INNOVATIONS, LLC
Reel/Frame 069386/0933 →
SECURITY INTEREST Recorded Oct 31, 2024
From: MAJORO CARDIAC INNOVATIONS, LLC
To: HIGHLANDS, LLC
Reel/Frame 069094/0472 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 3, 2024
From: GORMAN, ROBERT C., MD; GILLESPIE, MATTHEW J., MD; GORMAN, JOSEPH H., III, MD
To: MAJORO CARDIAC LNNOVATIONS, LLC
Reel/Frame 068788/0653 →
CORRECTIVE ASSIGNMENT TO CORRECT THE CORRECT THE ASSIGNOR(S) AND ASSIGNEE(S) PREVIOUSLY RECORDED AT REEL: 68584 FRAME: 1. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Sep 16, 2024
From: THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA
To: GORMAN, ROBERT C., MD; GILLESPE, MATTHEW J., MD; GORMAN, JOESPH H., III, MD
Reel/Frame 068964/0086 →
CONFIRMATION OF ASSIGNMENT Recorded Aug 14, 2024
From: GORMAN, ROBERT C., MD; GILLESPIE, MATTHEW J., MD; GORMAN, JOSEPH H., III, MD
To: THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA
Reel/Frame 068584/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 17, 2023
From: GORMAN, JOSEPH H., III; GORMAN, ROBERT C.; GILLESPIE, MATTHEW J.
To: THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA
Reel/Frame 063342/0604 →
Continuity (6)
Continuation 16656787 · Oct 18, 2019
Continuation 15074451 · Mar 18, 2016
Continuation 15015736 · Feb 4, 2016
Continuation 13505885
Provisional Application 61258331 · Nov 5, 2009
Related Publication 20230248517A1 · Aug 10, 2023
References Cited (84)
US 5685306A · Davidson · 1997 [cited by applicant]
US 5957949A · Leonhardt et al. · 1999 [cited by applicant]
US 6398758B1 · Jacobsen et al. · 2002 [cited by applicant]
US 6551302B1 · Rosinko et al. · 2003 [cited by applicant]
US 6669719B2 · Wallace et al. · 2003 [cited by applicant]
US 6790229B1 · Berreklouw · 2004 [cited by applicant]
US 6790230B2 · Beyersdorf et al. · 2004 [cited by applicant]
US 7270675B2 · Chun et al. · 2007 [cited by applicant]
US 7335218B2 · Wilson et al. · 2008 [cited by applicant]
US 7338467B2 · Lutter · 2008 [cited by applicant]
US 8236049B2 · Rowe et al. · 2012 [cited by applicant]
US 8252051B2 · Chau et al. · 2012 [cited by applicant]
US 8323336B2 · Hill et al. · 2012 [cited by applicant]
US 8449599B2 · Chau et al. · 2013 [cited by applicant]
US 8579964B2 · Lane et al. · 2013 [cited by applicant]
US 8585755B2 · Chau et al. · 2013 [cited by applicant]
US 8828078B2 · Salahieh et al. · 2014 [cited by applicant]
US 9289291B2 · Gorman et al. · 2016 [cited by applicant]
US 20010021872A1 · Bailey et al. · 2001 [cited by applicant]
US 20030009213A1 · Yang · 2003 [cited by applicant]
US 20030023303A1 · Palmaz et al. · 2003 [cited by applicant]
US 20040106976A1 · Bailey et al. · 2004 [cited by applicant]
US 20050137688A1 · Salahieh et al. · 2005 [cited by applicant]
US 20050137691A1 · Salahieh et al. · 2005 [cited by applicant]
US 20060020334A1 · Lashinski et al. · 2006 [cited by applicant]
US 20060058872A1 · Salahieh et al. · 2006 [cited by applicant]
US 20060195183A1 · Navia et al. · 2006 [cited by applicant]
US 20060224183A1 · Freudenthal · 2006 [cited by applicant]
US 20060259135A1 · Navia et al. · 2006 [cited by applicant]
US 20070016286A1 · Herrmann et al. · 2007 [cited by applicant]
US 20070142906A1 · Figulla et al. · 2007 [cited by applicant]
US 20070213813A1 · Von et al. · 2007 [cited by applicant]
US 20070239265A1 · Birdsall · 2007 [cited by applicant]
US 20070244544A1 · Birdsall et al. · 2007 [cited by applicant]
US 20080183130A1 · Lutter · 2008 [cited by applicant]
US 20080188928A1 · Salahieh et al. · 2008 [cited by applicant]
US 20080215144A1 · Ryan et al. · 2008 [cited by applicant]
US 20080221672A1 · Lamphere et al. · 2008 [cited by applicant]
US 20080228263A1 · Ryan · 2008 [cited by applicant]
US 20080243151A1 · Binmoeller et al. · 2008 [cited by applicant]
US 20080275540A1 · Wen · 2008 [cited by applicant]
US 20090005863A1 · Goetz et al. · 2009 [cited by applicant]
US 20090112309A1 · Jaramillo et al. · 2009 [cited by applicant]
US 20090222076A1 · Figulla et al. · 2009 [cited by applicant]
US 20100036479A1 · Hill et al. · 2010 [cited by applicant]
US 20100298931A1 · Quadri et al. · 2010 [cited by applicant]
US 20100312333A1 · Navia et al. · 2010 [cited by applicant]
DE 102005052628A1 · 2007 [cited by applicant]
DE 102006052564B3 · 2007 [cited by applicant]
EP 2047824A1 · 2009 [cited by applicant]
JP 2000037403A · 2000 [cited by applicant]
JP 2003518984A · 2003 [cited by applicant]
JP 2008526379A · 2008 [cited by applicant]
JP 2009514628A · 2009 [cited by applicant]
WO 2006076325A1 · 2006 [cited by applicant]
WO 2006089236A1 · 2006 [cited by applicant]
WO 2006113906A1 · 2006 [cited by applicant]
WO 2006138173A2 · 2006 [cited by applicant]
WO 2007051620A1 · 2007 [cited by applicant]
WO 2007081820A1 · 2007 [cited by applicant]
WO 2007149933A2 · 2007 [cited by applicant]
WO 2008028569A1 · 2008 [cited by applicant]
WO 2008031103A2 · 2008 [cited by applicant]
WO 2008035337A2 · 2008 [cited by applicant]
WO 2008070797A2 · 2008 [cited by applicant]
WO 2008089365A2 · 2008 [cited by applicant]
WO 2008095475A2 · 2008 [cited by applicant]
WO 2009132187A1 · 2009 [cited by applicant]
WO 2010057262A8 · 2010 [cited by applicant]
WO 2010112844A1 · 2010 [cited by applicant]
WO 2010127041A1 · 2010 [cited by applicant]
WO 2011069048A2 · 2011 [cited by applicant]
WO 2011106533A1 · 2011 [cited by applicant]
WO 2011137531A1 · 2011 [cited by applicant]
WO 2012011108A2 · 2012 [cited by applicant]
Boudjemline et al., “Steps toward the percutaneous replacement of atrioventricular valves an experimental study”, J. Am. Coll. Cardiol., Jul. 19, 2005, 46(2), 360-365. [cited by applicant]
Definition of “enfold”; https://www.google.com/search?q=define+enfold&rlz=1C1GCEA_en&oq=define&aqs=chrome.0.69i5913j69i57j0i10i433i512j0i10i1311433i512j0i10i433i512j0i51213.17024j0j1&sourceid=chrome&ie=UTF-8. [cited by applicant]
Dwivedi et al., “Reference values for mitral and tricuspid annular dimensions using two-dimensional echocardiography”, Echo Research and Practice, Dec. 2014, 1(2), 43-50. [cited by applicant]
European Patent Application No. 10829157.6; Extended Search Report; dated Apr. 5, 2016; 13 pages. [cited by applicant]
https://www.ncbi.nim.nih.gov/pmc/articles/PMC4676479/, Reference values for mitral and tricuspid annular dimensions using two-dimensional echocardiography, Sep. 24, 2014, Queen Elizabeth Hospital, University Hospital Bi… [cited by applicant]
International Patent Application No. PCT/US2010/055645: International Search Report and Written Opinion dated Jan. 10, 2011, 9 pages. [cited by applicant]
Lozonschi et al., Transapical mitral valved stent implantation, Ann Thorac Surg., 2008, Sep. 86(3), 745-748. [cited by applicant]
Ma et al., “Double-Crowned Valved Stents for off-pump mitral valve replacement”, Eur. J. Cardiothorac Surg., Aug. 2005, 28(2), 194-198. [cited by applicant]
U.S. Appl. No. 15/425,915. [cited by applicant]